The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species
Abstract
Hepatotoxic doses of acetaminophen to mice produce not only acetaminophen-protein adducts in the centrilobular cells of the liver, but nitrotyrosine-protein adducts in the same cells, the site of the necrosis. Nitration of tyrosine occurs with peroxynitrite, a species formed by reaction of nitric oxide (NO · ) with superoxide (O 2 ·− ). Because NO · and O 2 ·− may be produced by activated Kupffer cells and/or infiltrated macrophages, we pretreated mice with the macrophage inactivators/depeleters gadolinium chloride (7 mg/kg, intravenously [iv]) or dextran sulfate (10 mg/kg, iv) 24 hours before administration of acetaminophen (300 mg/kg). Mice treated with acetaminophen plus gadolinium chloride, or acetaminophen plus dextran sulfate, had significantly less evidence of hepatotoxicity as evidenced by lower serum alanine transaminase (ALT) levels (28 ± 1 IU/L and 770 ± 240 IU/L, respectively) at 8 hours compared with acetaminophen (6,380 ± 408 IU/L). Analysis of hepatic homogenates for acetaminophen-protein adducts at 2 hours, a time of maximal covalent binding and before hepatocyte lysis, indicated that these pretreatments did not decrease covalent binding. Western blot analysis for the macrophage marker protein F4/80 in homogenates revealed not only the expected decrease by the macrophage inactivators/depleters, but also an apparent increase in acetaminophen-only-treated mice. At 8 hours nitrotyrosine-protein adducts were present in the acetaminophen-only-treated mice, but not in the acetaminophen plus gadolinium chloride-treated mice, or acetaminophen plus dextran sulfate-treated mice. High levels of heme-protein adducts, a measure of oxidative stress, were detected in livers of the 8 hour acetaminophen-only-treated mice. These data suggest that acetaminophen hepatotoxicity is mediated by an initial metabolic activation and covalent binding, and subsequent activation of macrophages to form O 2 ·− , NO · , and peroxynitrite. Nitration of tyrosine correlates with toxicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cytochrome P450 (CYP450) system, especially CYP2E1, has been known to enhance the toxic damage caused by paracetamol by increasing the formation of NAPQI.
“On the other hand, cytochrome P450 (CYP450) system, especially CYP2E1 has been known to enhance the toxic damage caused by paracetamol by increasing the formation of NAPQI. 5”
From Caralluma umbellata Haw. protects liver against paracetamol toxicity and inhibits CYP2E1 (2017) · cites this paper as [5]
Paracetamol toxicity is mainly due to reduction of hepatocyte GSH and increased CYP2E1 activity.
“The mechanism behind paracetamol toxicity is mainly due to the reduction of hepatocyte GSH and increased CYP2E1 activity where paracetamol is metabolized to an extremely reactive toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI) along with generation of reactive oxygen species in augmenting oxidative stress. 3,5,6”
From Caralluma umbellata Haw. protects liver against paracetamol toxicity and inhibits CYP2E1 (2017) · cites this paper as [5]
Paracetamol is metabolized to the reactive toxic metabolite NAPQI, with generation of reactive oxygen species that augment oxidative stress.
“The mechanism behind paracetamol toxicity is mainly due to the reduction of hepatocyte GSH and increased CYP2E1 activity where paracetamol is metabolized to an extremely reactive toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI) along with generation of reactive oxygen species in augmenting oxidative stress. 3,5,6”
From Caralluma umbellata Haw. protects liver against paracetamol toxicity and inhibits CYP2E1 (2017) · cites this paper as [5]
Citations
Cites
The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide
Pryor, W. A., & Squadrito, G. L. (1995) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1995.268.5.l699 · Cited by 1,511
Flagged first, then by citations
Research works printed but not linked: 40
- Hinson, 1980, Rev Biochem Toxicol, 2, 103
- Dahlin, 1984, Proc Natl Acad Sci U S A, 81, 1327, 10.1073/pnas.81.5.1327 · DOI · Paper page
- Mitchell, 1973, J Pharmacol Exp Ther, 187, 211
- Jollow, 1973, J Pharmacol Exp Ther, 187, 195
- Hinson, 1995, Drug Metab Rev, 27, 73, 10.3109/03602539509029816 · DOI
- Roberts, 1991, Am J Pathol, 138, 359
- Cohen, 1997, Drug Metab Rev, 29, 59, 10.3109/03602539709037573 · DOI
- Bartolone, 1987, Biochem Pharmacol, 36, 1193, 10.1016/0006-2952(87)90069-4 · DOI
- Cohen, 1997, Toxicol Appl Pharmacol, 143, 1, 10.1006/taap.1996.8074 · DOI
- Laskin, 1995, Ann Rev Pharmacol Toxicol, 35, 655, 10.1146/annurev.pa.35.040195.003255 · DOI
- Winwood, 1993, Semin Liver Dis, 13, 733, 10.1055/s-2007-1007337 · DOI
- Blazka, 1996, J Inflamm, 47, 138
- Goldin, 1996, J Pathol, 179, 432, 10.1002/(SICI)1096-9896(199608)179:4<432::AID-PATH609>3.0.CO;2-S · DOI
- Laskin, 1995, Hepatology, 21, 1045, 10.1002/hep.1840210424 · DOI
- Nakae, 1990, Am J Pathol, 136, 787
- Hinson, 1998, Chem Res Toxicol, 11, 604, 10.1021/tx9800349 · DOI · Paper page
- Beckman, 1996, Am J Physiol, 271, c1424, 10.1152/ajpcell.1996.271.5.C1424 · DOI · Paper page
- Pryor, 1995, Am J Physiol, 268, l699
- Beckman, 1994, Biol Chem Hoppe-Seyler, 375, 81, 10.1515/bchm3.1994.375.2.81 · DOI
- Gardner, 1998, Hepatology, 27, 748, 10.1002/hep.510270316 · DOI
- Matthews, 1996, Drug Metab Dispos, 24, 1192
- Vuletich, 1998, Toxicologist, 42, 219s
- Pumford, 1989, J Pharmacol Exp Ther, 248, 182
- Hirsch, 1982, Immunobiology, 161, 298, 10.1016/S0171-2985(82)80086-7 · DOI
- Hume, 1984, Anat Rec, 210, 503, 10.1002/ar.1092100311 · DOI
- McKnight, 1996, J Biol Chem, 271, 486, 10.1074/jbc.271.1.486 · DOI
- MacMicking, 1997, Annu Rev Immunol, 15, 323, 10.1146/annurev.immunol.15.1.323 · DOI
- Roland, 1996, J Leukoc Biol, 60, 487, 10.1002/jlb.60.4.487 · DOI
- Hardonk, 1992, J Leukoc Biol, 52, 296, 10.1002/jlb.52.3.296 · DOI
- Walker, 1981, Toxicol Appl Pharmacol, 59, 500, 10.1016/0041-008X(81)90303-3 · DOI
- Lee, 1985, J Exp Med, 161, 475, 10.1084/jem.161.3.475 · DOI
- Hagen, 1994, Proc Natl Acad Sci U S A, 91, 12808, 10.1073/pnas.91.26.12808 · DOI
- Boess, 1998, Hepatology, 27, 1021, 10.1002/hep.510270418 · DOI
- Scott, 1984, Invest Ophthalmol Vis Sci, 25, 599
- Sies, 1997, J Biol Chem, 272, 27812, 10.1074/jbc.272.44.27812 · DOI
- Padmaja, 1998, Arch Biochem Biophys, 349, 1, 10.1006/abbi.1997.0407 · DOI
- DeLeve, 1997, Biochem Pharmacol, 53, 1339, 10.1016/S0006-2952(97)00048-8 · DOI
- Kuo, 1994, J Surg Res, 56, 594, 10.1006/jsre.1994.1094 · DOI
- Alexander, 1998, Nutrition, 14, 376, 10.1016/S0899-9007(97)00492-9 · DOI
- Dai, 1995, J Pharmacol Exp Ther, 273, 1497
Cited by
Sorted by citations
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Dixon, L. J., Barnes, M., Tang, H., Pritchard, M. T., & Nagy, L. E. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120026 · Cited by 628
Dambach, D. M., Watson, L. M., Gray, K. R., Durham, S. K., & Laskin, D. L. (2002) · Hepatology · doi:10.1053/jhep.2002.33162 · Cited by 289
James, L. P. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg181 · Cited by 244
LeFort, K. R., Rungratanawanich, W., & Song, B.-J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05061-7 · Cited by 202
Early Hepatic Microvascular Injury in Response to Acetaminophen Toxicity
ITO, Y., BETHEA, N. W., ABRIL, E. R., & MCCUSKEY, R. S. (2003) · Microcirculation · doi:10.1038/sj.mn.7800204 · Cited by 158
Abdelmegeed, M. A., Jang, S., Banerjee, A., Hardwick, J. P., & Song, B.-J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.018 · Cited by 85
Fungal dissemination is limited by liver macrophage filtration of the blood
Sun, D., Sun, P., Li, H., Zhang, M., Liu, G., Strickland, A. B., Chen, Y., Fu, Y., Xu, J., Yosri, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12381-5 · Cited by 83
Abdelmegeed, M. A., Moon, K.-H., Chen, C., Gonzalez, F. J., & Song, B.-J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.07.016 · Cited by 81
Bae, M.-A., Pie, J.-E., & Song, B. J. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12313-9 · Cited by 60
Nitric oxide releasing acetaminophen (nitroacetaminophen)
Moore, P. K., & Marshall, M. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(03)00052-5 · Cited by 33
Biagioli, M., Marchianò, S., di Giorgio, C., Roselli, R., Bordoni, M., Bellini, R., Fiorillo, B., Sepe, V., Catalanotti, B., Cassiano, C., et al. (2023) · Hepatology · doi:10.1002/hep.32787 · Cited by 28
Caralluma umbellata Haw. protects liver against paracetamol toxicity and inhibits CYP2E1
Bellamakondi, P. K., Godavarthi, A., & Ibrahim, M. (2017) · BioImpacts · doi:10.15171/bi.2018.04 · Cited by 15
Metadata
- Authors
- Michael, S. L., Pumford, N. R., Mayeux, P. R., Niesman, M. R., & Hinson, J. A.
- Affiliations
- University of Arkansas for Medical Sciences (US)
- Corresponding author
- Hinson, Jack A.
- ORCID
- Niesman, Michael R.
- Venue
- Hepatology
- Published
- 1999-07
- Volume
- 30
- Issue
- 1
- Pages
- 186-195
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2033635345
- Cited by
- 335
- References
- 1
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 8 · 2023: 6 · 2022: 9 · 2021: 8 · 2020: 13 · 2019: 9 · 2018: 11 · 2017: 18 · 2016: 9 · 2015: 14 · 2014: 17 · 2013: 13 · 2012: 21
- FWCI
- 7.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM058884, R01GM048749)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK44716)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- acetaminophen hepatotoxicity, gadolinium chloride, dextran sulfate, Kupffer cells, macrophages, peroxynitrite, nitric oxide, superoxide, reactive oxygen species, reactive nitrogen species, oxidative stress, F4/80, alanine aminotransferase, liver necrosis
- MeSH terms
- Acetaminophen, Alanine Transaminase, Animals, Anti-Inflammatory Agents, Aspartate Aminotransferases, Gadolinium, Kupffer Cells, Liver, Macrophage Activation, Macrophages, Male, Mice, Inbred Strains, Necrosis, Nitrates, Nitric Oxide, Superoxides, Dextran Sulfate, Oxidants, Reactive Oxygen Species, Oxidative Stress, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review